Work

Abstract 18502: Mass and Genetic Polymorphism of Group IIA Secretory Phospholipase A2, Rosuvastatin Therapy, and Risk of Cardiovascular Events: An Analysis From the JUPITER Trial

Year: 2015

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.132.suppl_3.18502

Authors: Akintunde O Akinkuolie, Audrey Y Chu, Michael Caulfield, Jianying Mu, Hurt-Camejo Eva, Bo Ding, Fredrik Nyberg, Robert J Glynn, Paul M Ridker, Daniel I Chasman, Samia Mora

Institutions: Brigham and Women's Hospital, Harvard University, Quest Diagnostics (United States), Karolinska Institutet, AstraZeneca (Sweden)

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2894420371

Cites:

Cited by: 1

Related to: 10